| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |